AirTouch F20: The softest CPAP mask from ResMed
AirTouch F20 UltraSoft memory foam cushion

ResMed announced it's softest mask ever, the AirTouch F20 full face mask with UltraSoft memory foam cushion that adapts to the contours of each patient's face, creating a personalized fit for the ultimate experience in cushion comfort. Learn more in the press release, pictures and video below.

Introducing the Softest CPAP Mask from ResMed
ResMed AirTouch™ F20 full face mask with UltraSoft™ memory foam keeps patients on CPAP therapy comfortable throughout the night
It’s very exciting to offer our patients something that’s truly new and different. –Jared Eardley, clinical supervisor, Norco Inc.

SAN DIEGO – May 16, 2017 – ResMed (NYSE: RMD) today announced its AirTouch F20 full face mask with UltraSoft memory foam mask cushion, a breakthrough in the treatment of sleep apnea.

The cushion adapts to the contours of each patient’s face, creating a personalized fit for the ultimate experience in cushion comfort:

  • Designed to reduce facial markings and skin irritation – even when sealed firmly against the skin – AirTouch fits 98% of patient faces.
  • Permeable foam creates a uniquely natural, breathable seal that allows some excess heat and sweat to escape through the cushion without compromising therapy pressure.
  • Compatible with any CPAP, including the world’s smallest CPAP, ResMed’s new AirMini™.
  • Easy to maintain and designed to seal at a range of therapy pressures, and to fit the same mask frame as the AirFit™ F20, which uses the InfinitySeal™ silicone cushion – so patients can easily try and choose the material they prefer best.

“With its unprecedented comfort, the AirTouch F20 is setting a new standard for CPAP therapy,” said Mick Farrell, ResMed CEO. “Since many patients spend all night, every night sleeping with their mask, we want all patients to be as comfortable and happy with their therapy and their sleep as possible. AirTouch takes ResMed's market-leading mask comfort to the next level.”

Comfort is the #1 reason patients quit CPAP (continuous positive airway pressure) therapy, the gold standard for treating sleep apnea, which affects more than 100 million people worldwide. Untreated sleep apnea causes sufferers to stop breathing repeatedly throughout the night, unconsciously transitioning between moments of sleep suffocation and jolts of awakening to resume breathing. This may cause dangerous levels of daytime fatigue and raise the risk of developing other fatal conditions like type 2 diabetes and heart failure.

To help more patients stay on therapy, ResMed’s mask developers have spent the last decade perfecting its UltraSoft memory foam cushion to give patients a whole new choice in comfort that still seals effectively over a range of therapy pressures.

“It’s very exciting to offer our patients something that’s truly new and different,” said Jared Eardley, clinical supervisor at Norco Inc., a home medical equipment provider in Meridian, Idaho. “Plus, being able to pop the cushion on to a patient’s own AirFit F20 frame will save time and hassle for both the patients and my staff – it’s a real win-win.”

Today, U.S. and Canadian patients can order the AirTouch F20 from their home medical equipment provider. It will be available in select countries across South America, Europe, and Asia in the coming months. For a complete country list, product photos, videos, and scientific claims made above, please visit newsroom.resmed.com/airtouch-f20-press-kit

About ResMed

ResMed (NYSE: RMD) changes lives with award-winning medical devices and cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 3 million patients remotely monitored every day. Our 5,000-strong team is committed to creating the world’s best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 100 countries.­­ ResMed.com | Facebook | Twitter | LinkedIn

# # #

For media: Alison Graves, 858.836.6789, news@resmed.com For investors: Agnes Lee, 858.836.5971, investorrelations@resmed.com
Media contacts - Bottom Blue - All Interior Pages

Media contacts

Global

Alison Graves
(858) 836-6789

Americas

Jayme Rubenstein
(858) 836-6798

EMEA, Japan

Christine Many Lacoste
(33) 04-26-10-02-43

Asia-Pacific

Paul McKeon
(61) 2-8884-2596

ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages